EPIC PHARMA LLC
GenericsEPIC PHARMA LLC is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Gastroenterology. Key products include LAMIVUDINE AND ZIDOVUDINE.
EPIC PHARMA LLC's Key Drugs
EPIC PHARMA LLC's core commercial portfolio centers on OLANZAPINE AND FLUOXETINE HYDROCHLORIDE, BUCAPSOL, KLAYESTA, spanning Cardiovascular and Infectious Disease — its most strategically important drugs approved in the last 15 years.
EPIC PHARMA LLC's Recent FDA Approvals
EPIC PHARMA LLC secured 1 new FDA approval for novel drugs (NDA/BLA) in the last two years.
EPIC PHARMA LLC's Therapeutic Areas
EPIC PHARMA LLC's approved drugs and pipeline span 5 therapeutic areas, led by Cardiovascular and Infectious Disease, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
EPIC PHARMA LLC's Top Competitors
EPIC PHARMA LLC's closest competitors by therapeutic-area and drug-target overlap include Pfizer, APOTHECON, and Baxter. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
EPIC PHARMA LLC Pipeline Snapshot
Active clinical trials for EPIC PHARMA LLC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • OLANZAPINE AND FLUOXETINE HYDROCHLORIDE leads revenue
- • 3 key drugs tracked
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Discontinued (1)
Company Info
- First Approval
- 1952-11-17
- Latest
- 2026-06-18
- Applications
- 201